| |
|
Dr. Roger Korman, Chairman and CEO
Dr. Korman worked for 25 years in international business for IMS Health (NYSE:RX), the world leader in information services to the pharmaceutical industry. He led product development in the U.S. and served as Managing Director of the U.K. Dr. Korman grew the Canadian business to fourth largest in the IMS worldwide portfolio, in the process winning the Globe and Mail Top 50 Companies in Canada twice and the Macleans Top 100 Companies in Canada three times. Recently retired as Chief Executive Officer of IMS Health Canada and Latin America, Dr. Korman brings a wealth of expertise and industry contacts to the Aptilon team. Dr. Korman obtained a Masters degree in quantitative research from Temple University and his M.S.S. and Ph.D. from the Bryn Mawr Graduate School of Social Work and Social Research.
|
|
